Royal Society of Chemistry, Dalton Transactions, 35(51), p. 13157-13175, 2022
DOI: 10.1039/d2dt02040h
Full text: Unavailable
The strategy of targeting phthalocyanine photosensitizers by conjugation to different classes of anticancer drugs for improved phototherapy is reviewed.